19th International Conference on Alzheimer’s Drug Discovery

The purpose for this annual Alzheimer’s Drug Discovery Foundation (ADDF) conference is to accelerate the development of innovative treatments for Alzheimer’s disease, related dementias and cognitive aging.

Attendees will see the diverse cutting-edge approaches ADDF scientists are undertaking and have opportunities for networking and partnership discussions with academic, industry, and foundation thought leaders.

The two-day meeting is organized around four sub-topics:

I. Neuroinflammation;

II. Neuroprotection and Neural Regeneration;

III. Epigenetics and Cognitive Enhancing; and

IV. Misfolded Proteins and Proteostasis.

Termine und Preise
17.09. - 18.09.2018
/ Ab 17:00 Uhr
Jersey City (Vereinigte Staaten von Amerika)
/ Hyatt Regency Jersey City
Early Bird before Aug 10 Standard Aug 11 - Sep 16 At door Sep 17 - Sep 18
Post-Doctoral Students, Grad. Students $ 225,00 $ 300,00 $ 375,00
Academic / Government $ 300,00 $ 375,00 $ 425,00
Non-Profit Organization $ 300,00 $ 375,00 $ 425,00
Start-up Biotechnology Company $ 300,00 $ 375,00 $ 425,00
Industry and Private Parctice $ 550,00 $ 650,00 $ 700,00
Reception Guest $ 35,00 $ 35,00 $ 35,00
Media $ 0,00 $ 0,00 $ 0,00





Informationen anfordern

19th International Conference on Alzheimer’s Drug Discovery

Bitte auswhlen.
  • Anrede:*
###_DT45_###
###_DT46_###
  • Anrede: *
Bitte geben Sie einen Vornamen ein.
Bitte geben Sie einen Nachnamen ein.
Bitte geben Sie eine E-Mail-Adresse ein.